Key facts
- It has raised $236.0M.
- Notable investors include August Global Partners, Mekong Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Gene Solutions (Laboratory Services (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Gene Solutions (Laboratory Services (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gene Solutions (Laboratory Services (Healthcare))
Developer of genetic research and diagnostic technology designed to improve public health. The company offers care products for pregnancy, prenatal diagnosis, control of general diseases, cancer biology, and disease diagnosis, providing patients with genetic tests that enhance screening, diagnosis, and treatment at affordable costs.
- Sector
- Healthcare
- HQ
- Ho Chi Minh City, Vietnam
- Founded
- 2017
- Employees
- 700
- Website
- genesolutions.vn/
- Ownership
- Privately Held (backing)
Gene Solutions (Laboratory Services (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gene Solutions (Laboratory Services (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gene Solutions (Laboratory Services (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.